Evidence map›Paper›PMID 23066029›Full record

ArticleThe Journal of biological chemistry2012

Inhibition of DNA damage-induced apoptosis through Cdc7-mediated stabilization of Tob.

Toru Suzuki, Junko Tsuzuku, Akiyo Hayashi, Yasushi Shiomi, Hiroko Iwanari, Yasuhiro Mochizuki, Takao Hamakubo, Tatsuhiko Kodama, Hideo Nishitani, Hisao Masai and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. The emerging role for Cullin 4 family of E3 ligases in tumorigenesis.Biochimica et biophysica acta. Reviews on cancer · 2019
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Toru SuzukiDepartment of Cancer Biology, Division of Oncology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Tokyo 108-8639, Japan.
Junko Tsuzuku
Akiyo Hayashi
Yasushi Shiomi
Hiroko Iwanari
Yasuhiro Mochizuki
Takao Hamakubo
Tatsuhiko Kodama
Hideo Nishitani
Hisao Masai
Tadashi Yamamoto
The University of Tokyo · JPUniversity of Hyogo · JPTokyo Metropolitan Institute of Medical Science · JPTokyo University of Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPreventing unnecessary cell death is essential for DNA-damaged cells to carry out the DNA repair process.

resultsCdc7 inhibits the Cul4-DDB1(Cdt2)-dependent Tob degradation.

conclusionCdc7 enables mild DNA-damaged cells to keep their viability by competing with the Tob degradation system. SIGNIFICANCE: Cells deal with moderate DNA damage not only by cessation of the cell cycle but also through direct mediated pro-survival signaling. Cells respond to DNA damage by activating alternate signaling pathways that induce proliferation arrest or apoptosis. The correct balance between these two pathways is important for maintaining genomic integrity and preventing unnecessary cell death. The mechanism by which DNA-damaged cells escape from apoptosis during DNA repair is poorly understood. We show that the DNA replication-initiating kinase Cdc7 actively prevents unnecessary death in DNA-damaged cells. In response to mild DNA damage, Tob levels increase through both a transcriptional mechanism and protein stabilization, resulting in inhibition of pro-apoptotic signaling. Cells lacking Cdc7 expression undergo apoptosis after mild DNA damage, where Cul4-DDB1(Cdt2) induces Tob ubiquitination and subsequent degradation. Cdc7 phosphorylates and interacts with Tob to inhibit the Cul4-DDB1(Cdt2)-dependent Tob degradation. Thus, Cdc7 defines an essential pro-survival signaling pathway by contributing to stabilization of Tob, thereby the viability of DNA-damaged cells being maintained.

Indexed as

ApoptosisDNA DamageCell Cycle ProteinsCell Line, TumorDNA-Binding ProteinsDown-RegulationHumansIntracellular Signaling Peptides and ProteinsNuclear ProteinsProtein BindingProtein Serine-Threonine KinasesProteolysisSignal TransductionTumor Suppressor ProteinsUbiquitin-Protein LigasesCDC7 protein, humanCell Cycle ProteinsDDB1 protein, humanDNA-Binding ProteinsDTL protein, humanIntracellular Signaling Peptides and ProteinsNuclear ProteinsProtein Serine-Threonine KinasesTOB1 protein, humanTumor Suppressor ProteinsUbiquitin-Protein Ligases

Identifiers

PMID23066029
PMCPMC3504742
OpenAlexW1999866559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.